CSPC Is One of the Largest Chinese Pharmaceutical Companies With Diversified Pipeline Portfolios
Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
US tariff threat on Indian generics: What it means for pharma
Tariffs on Indian generics could raise US drug prices, disrupt supply chains, and strain insurance systems. Indian firms, ...